Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
for Low Grade Upper Tract Urothelial Carcinoma
14 locations incl. Atlanta
Sponsor: Tyra Biosciences, Inc
Sex: All·Age: 18+
Code: NCT07265947·Phase 2·Recruiting·Listed Dec 2025